Synthesis 2009(3): 431-437  
DOI: 10.1055/s-0028-1083306
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

The First Synthesis of Allyl Isonitriles from Baylis-Hillman Adducts, and Their Application in the Synthesis of Substituted Imidazo[1,2-a]pyridines and Tetraazadibenzoazulenes [¹]

Maloy Nayaka, Sanjeev Kanojiyab, Sanjay Batra*a
a Medicinal and Process Chemistry Division, Central Drug Research Institute, PO Box 173, Lucknow 226 001, India
b SAIF Division, Central Drug Research Institute, PO Box 173, Lucknow 226 001, India
Fax: +91(522)2623405, +91(522)2623938; e-Mail: batra_san@yahoo.co.uk;
Further Information

Publication History

Received 11 August 2008
Publication Date:
09 January 2009 (online)

Abstract

The first report of the stereoselective synthesis of substituted allyl isonitriles from primary allylamines generated from Baylis­-Hillman adducts, and their utilization in a robust isonitrile-based multicomponent reaction in the presence of ammonium chloride to afford substituted imidazo[1,2-a]pyridines, is described.

1

CDRI Communication No. 7599.

    References

  • 2 Singh V. Batra S. Tetrahedron  2008,  64:  4511 
  • 3 Pathak R. Singh V. Nag S. Kanojiya S. Batra S. Synthesis  2006,  813 
  • 4a Pathak R. Batra S. Tetrahedron  2007,  63:  9448 
  • 4b Nag S. Madapa S. Batra S. Synthesis  2008,  101 
  • 4c Nag S. Mishra A. Batra S. Tetrahedron  2008,  64:  10162 
  • For a few examples only, see:
  • 5a Dömling A. Ugi I. Angew. Chem. Int. Ed.  2000,  39:  3168 ; and references cited therein
  • 5b Dömling A. Chem. Rev.  2006,  106:  17 ; and references cited therein
  • 5c Nair V. Rajesh C. Vinod AU. Bindu S. Sreekanth AR. Mathen JS. Balagopal L. Acc. Chem. Res.  2003,  36:  899 
  • 5d Akritopoulou-Zanze I. Curr. Opin. Chem. Biol.  2008,  12:  324 ; and references cited therein
  • 6a Hulme C. Lee Y.-S. Mol. Diversity  2008,  12:  1 ; and references cited therein
  • 6b Parchinsky VZ. Shuvalova O. Ushakova O. Kravchenko DV. Krasavin M. Tetrahedron Lett.  2006,  47:  947 
  • 6c DiMauro EF. Kennedy JM. J. Org. Chem.  2007,  72:  1013 
  • 6d Tu S. Li C. Li G. Cao L. Shao Q. Zhou D. Jiang B. Zhou J. Xia M. J. Comb. Chem.  2007,  9:  1144 
  • 6e Shaabani A. Rezazadeh F. Soleimani E. Monatsh. Chem.  2008,  139:  931 
  • For a few recent examples only, see:
  • 7a Enguehard-Gueiffier C. Gueiffier A. Mini-Rev. Med. Chem.  2007,  7:  888 
  • 7b Imaeda Y. Kawamoto T. Tobisu M. Konishi N. Hiroe K. Kawamura M. Tanaka T. Kubo K. Bioorg. Med. Chem.  2008,  16:  3125 
  • 7c Rether J. Erkel G. Anke T. Bajtner J. Sterner O. Bioorg. Med. Chem.  2008,  16:  1236 
  • 7d Buckley GM. Fosbeary R. Fraser JL. Gowers L. Higueruelo AP. James LA. Jenkins K. Mack SR. Morgan T. Parry DM. Pitt WR. Rausch O. Richard MD. Sabin V. Bioorg. Med. Chem. Lett.  2008,  18:  3656 
  • 7e Buckley GM. Ceska TA. Fraser JL. Gowers L. Groom CR. Higueruelo AP. Jenkins K. Mack SR. Morgan T. Parry DM. Pitt WR. Rausch O. Richard MD. Sabin V. Bioorg. Med. Chem. Lett.  2008,  18:  3291 
  • 7f Ismail MA. Arafa RK. Wenzler T. Brun R. Tanious FA. Wilson WD. Boykin DW. Bioorg. Med. Chem.  2008,  16:  683 
  • 7g Zimmermann PJ. Buhr W. Brehm C. Palmer AM. Feth MP. Senn-Bilfinger J. Simon W.-A. Bioorg. Med. Chem. Lett.  2007,  17:  5374 
  • 7h Gudmundsson KS. Johns BA. Bioorg. Med. Chem. Lett.  2007,  17:  2735 
  • 7i Scribner A. Dennis R. Hong J. Lee S. McIntyre D. Perrey D. Feng D. Fisher M. Wyvratt M. Leavitt P. Liberator P. Gurnett A. Brown C. Mathew J. Thompson D. Schmatz D. Biftu T. Eur. J. Med. Chem.  2007,  42:  1334 
  • 7j Cai D. Byth KF. Shapiro GI. Cancer Res.  2006,  66:  435 
1

CDRI Communication No. 7599.